Chronic Pain Market Report 2026

Chronic Pain Market Overview

• Chronic Pain market size has reached to $84.66 billion in 2025 • Expected to grow to $127.4 billion in 2030 at a compound annual growth rate (CAGR) of 8.6% • Growth Driver: Risk Of Chronic Pain Patients Drives Growth In The Chronic Pain Market • Market Trend: Strategic Partnerships Drive Innovations In Chronic Pain Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Chronic Pain Market?

Chronic pain refers to persistent or long-lasting pain that continues beyond the normal healing process of an injury or illness. Chronic pain can have various causes, including injuries, underlying medical conditions, nerve damage, inflammation, musculoskeletal disorders, and certain diseases such as arthritis, fibromyalgia, or neuropathy. The main products in chronic pain are drug and devices. A drug refers to a substance that is used to diagnose, prevent, or treat a disease or medical condition. Drugs such as opioids and non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used to alleviate pain symptoms and manage the underlying causes. These are used for various indications such as neuropathic pain, arthritis pain, chronic back pain, cancer pain, migraine, fibromyalgia, and others by various end users including hospitals, clinics, and research organizations.

What Is The Chronic Pain Market Growth Forecast?

The chronic pain market size is expected to see strong growth in the next few years. It will grow to $127.4 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing demand for personalized pain therapies, rising adoption of bioelectronic devices, expansion of telehealth-based pain care, growing focus on opioid alternatives, increased investment in pain research. Major trends in the forecast period include increasing adoption of multidisciplinary pain care models, rising use of neuromodulation devices, growing preference for non-opioid drug therapies, expansion of home-based pain management solutions, enhanced integration of digital health platforms.

Global Chronic Pain Market Segmentation

1) By Product: Drug, Devices 2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications 3) By End User: Hospitals, Clinics, Research Organization Subsegments: 1) By Drug: Non-Opioid Analgesics, Opioids, Antidepressants, Anticonvulsants, Topical Analgesics, Corticosteroids 2) By Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Units, Spinal Cord Stimulators, Intrathecal Drug Delivery Systems, Heat And Cold Therapy Devices, Bioelectronic Devices

What Is The Driver Of The Chronic Pain Market?

The prevalence of chronic pain patients is expected to propel the growth of the chronic pain market. Chronic pain patients refer to individuals who experience persistent or long-lasting pain that lasts beyond the normal healing process or persists for an extended period, typically exceeding three months. The high prevalence of chronic pain patients drives the growth of the chronic pain market, as the increasing demand for effective pain management solutions, including pharmaceuticals and medical devices, creates opportunities for innovation and development within the industry. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, an estimated 4.0 million Australians (16% of the population) were living with back problems in 2022. By 2023, back problems became the third leading cause of disease burden, contributing to 4.3% of the country's total disease burden. Additionally, in February 2024, according to another report published by the Institute for Health Metrics and Evaluation, a US-based national and international public health agency and research institute, the projected global cases of neck pain are expected to reach 269 million by 2050 (ranging from 219 to 322 million. Therefore, the prevalence of chronic pain patients is driving the growth of the chronic pain industry.

Key Players In The Global Chronic Pain Market

Major companies operating in the chronic pain market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Mitsubishi Chemical Group Corporation, GlaxoSmithKline plc., Eli Lilly and Company, AstraZeneca plc., Becton, Dickinson, and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Endo International plc., Noven Pharmaceuticals Inc., Anika Therapeutics Inc., Collegium Pharmaceutical Inc., Heron Therapeutics Inc., Paradigm Biopharmaceuticals Ltd., Braeburn Inc., Taiwan Liposome Company Ltd., Axial Healthcare, AcelRx Pharmaceuticals Inc., Centrexion Therapeutics Corp., Vertanical GmbH, IKI Health Group, Tonix Pharmaceuticals Inc., Paperplane Therapeutics

Global Chronic Pain Market Trends and Insights

Major companies operating in the chronic pain market are adopting a strategic partnership approach to launch a shared savings program for the management of chronic pain. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in August 2023, MOBĒ, a US-based digital health innovator company, partnered with Override Health, a US-based healthcare company. With this partnership, they aim to address the management of chronic pain through a shared savings program that combines their respective expertise. MOBE, as a health outcomes company, utilizes health care data analytics to inform its high-touch, one-to-one health coaching and medication management model. On the other hand, Override delivers an integrated program of virtual interdisciplinary care, neuroplasticity-centered coaching, and peer support to help individuals with chronic pain navigate the confusion of disconnected care.

What Are Latest Mergers And Acquisitions In The Chronic Pain Market?

In October 2024, Stryker Corporation, a US-based medical technology company, acquired Vertos Medical Inc. for an undisclosed amount. The acquisition was aimed to enhance unique, non-surgical solutions for interventionalists addressing chronic lower back pain while broadening their presence in ambulatory surgery centers. Vertos Medical Inc. is a US-based manufacturer of devices for chronic pain management, specifically focusing on treatments for chronic lower back pain caused by lumbar spinal stenosis.

Regional Outlook

North America was the largest region in the chronic pain market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Chronic Pain Market?

The chronic pain market consists of sales of opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), anticonvulsants, antidepressants, and other analgesics that are used to manage chronic pain. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Chronic Pain Market Report 2026?

The chronic pain market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chronic pain industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.